Arrhythmogenic right ventricular dysplasia screening: Difference between revisions
No edit summary |
|||
Line 17: | Line 17: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cardiology]] | |||
[[Category:Electrophysiology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 02:13, 23 September 2012
Arrhythmogenic right ventricular dysplasia Microchapters |
Differentiating Arrhythmogenic right ventricular dysplasia from other Diseases |
---|
Diagnosis |
Treatment |
Arrhythmogenic right ventricular dysplasia screening On the Web |
American Roentgen Ray Society Images of Arrhythmogenic right ventricular dysplasia screening |
Arrhythmogenic right ventricular dysplasia screening in the news |
Blogs onArrhythmogenic right ventricular dysplasia screening |
Directions to Hospitals Treating Arrhythmogenic right ventricular dysplasia |
Risk calculators and risk factors for Arrhythmogenic right ventricular dysplasia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Once hypertrophic cardiomyopathy is excluded, arrhythmogenic right ventricular dysplasia is a common cause of sudden cardiac death among competitive athletes.
Family Screening
All first degree family members of the affected individual should be screened for ARVD. This is used to establish the pattern of inheritance. Screening should begin during the teenage years unless otherwise indicated. Screening tests include:
- Echocardiogram
- EKG
- Signal averaged EKG
- Holter monitoring
- Cardiac MRI
- Exercise stress test